Concepedia

Paul Cain

PC

Statistics

Publications

4

Citations

98

H-Index

4

Active since

1981

Affiliations

Eli Lilly (United States)(Current)

Synta Pharmaceuticals (United States)

Paul Cain is an author at Eli Lilly (United States) specializing in autoimmune disease, autoimmunity, and immunodominance.

Top concepts

Publications per year

1981–2023

4

Publications

4

Impact of IgG subclass on molecular properties of monoclonal antibodies

Yu Tang, Paul Cain, Victor Anguiano et al. · mAbs · 2021 · 52 citations · Full text

, , +17

Impact of IgG subclass on monoclonal antibody developability

Paul Cain, Lihua Huang, Yu Tang et al. · mAbs · 2023 · 22 citations · Full text

, , +24

Structural analysis of the <i>mu</i>-chains synthesized by fetal liver hybridomas.

Thomas Μ. Kloppel, Ralph T. Kubo, Paul Cain et al. · The Journal of Immunology · 1981 · 14 citations · Full text

Pharmacokinetic Developability and Disposition Profiles of Bispecific Antibodies: A Case Study with Two Molecules

Amita Datta‐Mannan, Robin M. Brown, Stephanie Key et al. · Antibodies · 2021 · 10 citations · Full text

1–4 of 4